The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries

被引:148
|
作者
Halpin, D. M. G. [1 ]
Celli, B. R. [2 ]
Criner, G. J. [3 ]
Frith, P. [4 ]
Lopez Varela, M. V. [5 ]
Salvi, S. [6 ]
Vogelmeier, C. F. [7 ,8 ]
Chen, R. [9 ,10 ]
Mortimer, K. [11 ]
Montes de Oca, M. [12 ]
Aisanov, Z. [13 ]
Obaseki, D. [14 ]
Decker, R. [15 ]
Agusti, A. [16 ]
机构
[1] Univ Exeter, Med Sch, Coll Med & Hlth, Exeter, Devon, England
[2] Brigham & Womens Hosp, Pulm Div, 75 Francis St, Boston, MA 02115 USA
[3] Temple Univ, Lewis Katz Sch Med, Dept Thorac Med & Surg, Philadelphia, PA 19122 USA
[4] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia
[5] Univ Republ Hosp Maciel, Fac Med, Catedra Neumol, Montevideo, Uruguay
[6] Chest Res Fdn, Pune, Maharashtra, India
[7] Philipps Univ Marburg, Univ Med Ctr Giessen, Dept Med Pulm & Crit Care Med, Marburg, Germany
[8] Philipps Univ Marburg, DZL, German Ctr Lung Res, Marburg, Germany
[9] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China
[10] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China
[11] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England
[12] Univ Cent Venezuela, Hosp Univ Caracas, Caracas, Venezuela
[13] NI Pirogov Russian State Natl Res Med Univ, Dept Pulmonol, Healthcare Minist Russia, Moscow N, Russia
[14] Obafemi Awolowo Univ, Dept Med, Ife, Nigeria
[15] Global Initiat Chron Obstruct Lung Dis, Fontana, WI USA
[16] Univ Barcelona, Hosp Clin, Ctr Invest Biomed Red Enfermedades Resp, Inst Resp,Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain
关键词
COPD; epidemiology; global burden; AIR-FLOW OBSTRUCTION; LATIN-AMERICAN CITIES; FORCED VITAL CAPACITY; PRIMARY-CARE; PHYSICIAN PERCEPTIONS; ESSENTIAL MEDICINES; BIOMASS SMOKE; GLOBAL BURDEN; LUNG-FUNCTION; COPD RISK;
D O I
10.5588/ijtld.19.0397
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Chronic obstructive pulmonary disease (COPD) is one of the top three causes of death worldwide, but governments and non-governmental organisations have not given its prevention and treatment the priority it requires. This is particularly true in low- and middle-income countries, where most of the people suffering from this disease live. The United Nations (UN) has targeted a reduction of premature deaths from noncommunicable diseases (NCDs) by a third by 2030; however, a coordinated UN/World Health Organization (WHO) strategy to address the burden of COPD (one of the most important NCDs) is still lacking. To explore the extent of the problem and inform the development of policies to improve the situation, the Board of Directors of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) held a 1-day Summit. The key themes that emerged were the need to ensure accurate data on prevalence, raise awareness of the disease among the public, healthcare professionals and governments, including the fact that COPD aetiology goes beyond smoking (and other inhaled pollutants) and includes poor lung development in early life, and ensure that spirometry and both pharmacological and non-pharmacological therapies are available and affordable. Here, we present the actions that must be taken to address the impact of COPD. We believe that the WHO is particularly well-positioned to co-ordinate an attack on COPD, and GOLD will do all it can to help and rally support.
引用
收藏
页码:1131 / 1141
页数:11
相关论文
共 50 条
  • [31] Bioimaging and Subclinical Cardiovascular Disease in Low- and Middle-Income Countries
    Rajesh Vedanthan
    Brian G. Choi
    Usman Baber
    Jagat Narula
    Valentin Fuster
    Journal of Cardiovascular Translational Research, 2014, 7 : 701 - 710
  • [32] Cardiovascular disease in low- and middle-income countries: an urgent priority
    Wurie, Haja R.
    Cappuccio, Francesco P.
    ETHNICITY & HEALTH, 2012, 17 (06) : 543 - 550
  • [33] Bioimaging and Subclinical Cardiovascular Disease in Low- and Middle-Income Countries
    Vedanthan, Rajesh
    Choi, Brian G.
    Baber, Usman
    Narula, Jagat
    Fuster, Valentin
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2014, 7 (08) : 701 - 710
  • [34] Reducing the gap of chronic kidney disease in low- and middle-income countries: what is missing?
    Lopez, Dario Sebastian
    Vargas, Juliana Alexandra Hernandez
    Urina-Jassir, Manuel
    Urina-Triana, Miguel
    Franco, Oscar H.
    LANCET REGIONAL HEALTH-AMERICAS, 2023, 28
  • [35] Chronic kidney disease care models in low- and middle-income countries: a systematic review
    Stanifer, John W.
    Von Isenburg, Megan
    Chertow, Glenn M.
    Anand, Shuchi
    BMJ GLOBAL HEALTH, 2018, 3 (02):
  • [36] Uniting against antimicrobial resistance: opportunities for low- and middle-income countries at the London summit
    Bashar Haruna Gulumbe
    Abdulrakib Abdulrahim
    Bulletin of the National Research Centre, 48 (1)
  • [37] Raising the Profile of Pulmonary Education for Physicians in Low- and Middle-Income Countries
    Obaseki, Daniel O.
    Lugogo, Njira L.
    Buist, Sonia A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (04) : 458 - 459
  • [38] Challenges and Progress with Diagnosing Pulmonary Tuberculosis in Low- and Middle-Income Countries
    Harries, Anthony D.
    Kumar, Ajay M. V.
    DIAGNOSTICS, 2018, 8 (04):
  • [39] Limitations of telemedicine in low- and middle-income countries
    Kehayov, Ivo
    Uchikov, Petar
    Kitova, Tanya
    Kitov, Borislav
    NEUROSURGICAL FOCUS, 2022, 53 (03)
  • [40] Antifungal Stewardship in Low- and Middle-Income Countries
    Fernando Riera
    Juan Pablo Caeiro
    Claudia Elena Sotomayor
    Current Treatment Options in Infectious Diseases, 2019, 11 : 292 - 299